Skip to content

Illumina ILMN Acquisitions

Acquisitions at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$17.74B
Azenta logo
AzentaAZTA
$0
Agilent Technologies logo
Agilent TechnologiesA
$0
Danaher logo
DanaherDHR
$0-100%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$55.57M

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$29.2B+69.7%
Enterprise value$30.1B+63.8%
P/E35.4×+21.7×
P/S6.5×+2.5×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's acquisitions?
Illumina (ILMN) reported acquisitions of $415M in Q1 2026.
How has Illumina's acquisitions changed year-over-year?
Illumina's acquisitions increased by 5828.6% year-over-year, from $7M to $415M.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.